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Abstract: For patients with symptomatic unilateral internal carotid artery (ICA) occlusion, impaired
cerebrovascular reactivity (CVR) indicates increased stroke risk. Here, the role of collateral activation
remains a matter of debate, whereas angio-anatomical collateral abundancy does not necessarily imply
sufficient compensatory flow provided. We aimed to further elucidate the role of collateral activation in
the presence of impaired CVR. From a prospective database, 62 patients with symptomatic unilateral ICA
occlusion underwent blood oxygenation-level dependent (BOLD) fMRI CVR imaging and a transcranial
Doppler (TCD) investigation for primary and secondary collateral activation. Descriptive statistic and
multivariate analysis were used to evaluate the relationship between BOLD-CVR values and collateral ac-
tivation. Patients with activated secondary collaterals exhibited more impaired BOLD-CVR values of the
ipsilateral hemisphere (p = 0.02). Specifically, activation of leptomeningeal collaterals showed severely
impaired ipsilateral hemisphere BOLD-CVR values when compared to activation of ophthalmic collaterals
(0.05 ± 0.09 vs. 0.12 ± 0.04, p = 0.005). Moreover, the prediction analysis showed leptomeningeal col-
lateral activation as a strong independent predictor for ipsilateral hemispheric BOLD-CVR. In our study,
ipsilateral leptomeningeal collateral activation is the sole collateral pathway associated with severely
impaired BOLD-CVR in patients with symptomatic unilateral ICA occlusion.
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Abstract
For patients with symptomatic unilateral internal carotid artery (ICA) occlusion, impaired cerebrovascular reactivity
(CVR) indicates increased stroke risk. Here, the role of collateral activation remains a matter of debate, whereas angio-
anatomical collateral abundancy does not necessarily imply sufficient compensatory flow provided. We aimed to further
elucidate the role of collateral activation in the presence of impaired CVR. From a prospective database, 62 patients with
symptomatic unilateral ICA occlusion underwent blood oxygenation-level dependent (BOLD) fMRI CVR imaging and a
transcranial Doppler (TCD) investigation for primary and secondary collateral activation. Descriptive statistic and
multivariate analysis were used to evaluate the relationship between BOLD-CVR values and collateral activation.
Patients with activated secondary collaterals exhibited more impaired BOLD-CVR values of the ipsilateral hemisphere
(p¼ 0.02). Specifically, activation of leptomeningeal collaterals showed severely impaired ipsilateral hemisphere BOLD-
CVR values when compared to activation of ophthalmic collaterals (0.05 0.09 vs. 0.12 0.04, p¼ 0.005). Moreover,
the prediction analysis showed leptomeningeal collateral activation as a strong independent predictor for ipsilateral
hemispheric BOLD-CVR. In our study, ipsilateral leptomeningeal collateral activation is the sole collateral pathway
associated with severely impaired BOLD-CVR in patients with symptomatic unilateral ICA occlusion.
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Introduction
The presence of impaired cerebrovascular reserve
capacity (CVR) in patients with symptomatic unilateral
internal carotid artery (ICA) occlusion is associated
with increased stroke risk.1–3 The influence of collateral
activation in this matter remains a matter of debate,
since angio-anatomical collateral abundancy does not
necessarily imply sufficient compensatory flow provid-
ed.4–6 Importantly, anatomically prominent collaterals
may even reflect exhausted vasodilatation, and thereby
impaired CVR. From the literature, it is known that up
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to 50% of symptomatic patients with ICA occlusion
exhibit normal CVR,7 however the exact association
between collateral circulation and impaired hemody-
namic in those cases remains a matter of debate since
there are important limitations in assessing the ana-
tomical source of collateral flow status.
Collateral circulation is defined as alternate arterial
routes that are activated when normal blood flow
routes are insufficient. Using transcranial Doppler
(TCD), the cerebral collateral vessel status can be non-
invasively and inexpensively assessed with reliable eval-
uation of different intracranial blood flow patterns in
real-time.8 For TCD measurements of the cerebral cir-
culation, a distinction is made between primary and
secondary collateral pathways.9 Primary collaterals
are considered the anterior communicating artery
(ACOM) and posterior communicating artery
(PCOM) as part of the circle of Willis, whereas second-
ary collaterals include the ophthalmic artery and the
more distal leptomeningeal collaterals.10 The latter is
thought to be only recruited when the primary collat-
erals cannot be drawn upon or are insufficient to com-
pensate the blood flow demand.11
Ideally, to best study the relationship between collat-
eral activation and CVR, one would apply a multimodal
imaging approach to both assess the primary and
secondary collateral pathways as well as -downstream-
brain tissue perfusion. Blood oxygenation-level depen-
dent fMRI in combination with a standardized carbon
dioxide (CO2) stimulus can yield quantitative CVR
measurements at brain tissue level.12,13
We, therefore, studied the relationship between
BOLD-CVR in the ipsilateral hemisphere of symptomatic
patients with unilateral ICA occlusion and the activation
of primary and secondary collateral pathways as exam-
ined with TCD, to determine which pathway is involved
and activated in the presence of impaired BOLD-CVR.
Materials and methods
The research ethics board of the Canton Zurich,
Switzerland (Kantonale Ethikkommission Zurich;
KEK-ZH-Nr. 2012-0427) approved this prospective
ongoing cohort study, which is part of an interdisci-
plinary BOLD-CVR project in patients with symptom-
atic carotid artery disease. Written informed consent
was obtained from each participant before inclusion.
The study was conducted in accordance with the ethical
standards as laid down in the 1964 Declaration of
Helsinki and its later amendments.
Patient inclusion
During the study period from February 2015 till
February 2020, 78 patients with symptomatic carotid
artery occlusion presented at the Clinical Neuroscience
Center of the University Hospital Zurich, Switzerland
and were subsequently screened for participation.
Both, recently symptomatic patients (ischemic stroke
or transient ischemic attack (TIA) or transient monoc-
ular blindness (TMB) in the last 30 days before inclu-
sion) as well as formerly symptomatic patients
(ischemic stroke or TIA or TMB at earlier time
point) were included. Some patient data of this
cohort were previously reported.14
The inclusion criteria were: (1) patients aged 18 years
or above with symptomatic unilateral carotid artery
occlusion, (2) exhibiting focal neurologic symptoms
that are sudden in onset and ipsilateral to ICA occlu-
sion, including one or more transient ischemic attacks,
characterized by focal neurologic dysfunction or tran-
sient monocular blindness, or one or more minor (non-
disabling) ischemic strokes15 and (3) who also
underwent a TCD ultrasound examination within
three weeks of the BOLD-CVR examination.
Excluded from the study were those patients with
contraindications for MRI, intolerance for the soft
plastic mask or for the applied CO2 stimulus during
the BOLD-CVR fMRI examination. This was assessed
under direct supervision of the subject by applying the
CO2 stimulus outside the MRI system as a test-run.
Patients who suffered from additional relevant vascular
pathologies (>50% stenosis and/or occlusion) involv-
ing the anterior cerebral artery (ACA), middle cerebral
artery (MCA), posterior cerebral artery (PCA),
patients with additional relevant (50%) contralateral
ICA stenosis as well as bilateral steno-occlusive pathol-
ogies (such as Moyamoya disease) were excluded since
the additional pathologies could stimulate relevant lep-
tomeningeal collateralization. Also excluded were
patients with ICA dissection.
BOLD fMRI acquisition and processing
BOLD fMRI and CO2 stimulus. MRI data were acquired
on a 3-tesla Skyra VD13 scanner (Siemens
Healthineers, Forchheim, Germany) with a 32-channel
head coil. BOLD fMRI parameters and a three-
dimensional (3D) T1-weighted Magnetization
Prepared Rapid Acquisition Gradient Echo (MP
RAGE) image was performed in the same way as pub-
lished in our previous work.13
During the BOLD fMRI sequence, the carbon diox-
ide (CO2) stimulus was given with a computer con-
trolled gas blender with prospective gas targeting
algorithms (RespirActTM, Thornhill Research
Institute, Toronto, Canada). The RespirActTM allows
for precise targeting of arterial partial pressure CO2
while maintaining normal levels of O2 (iso-oxia).
16
During the CVR study, a standardized and controlled
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hypercapnic stimulus is applied (i.e. the patientsCO2
was increased 10mmHg above their resting CO2
value for 80 seconds).13
All the acquired raw BOLD fMRI volumes were
transferred to an external computer and pre-
processed with SPM 12 (Statistical Parameter
Mapping Software, Wellcome Department of Imaging
Neuroscience, University College of London, London,
UK). The BOLD fMRI volumes were processed and
aligned to the T1-weighted MP RAGE image as well as
smoothed with a Gaussian Kernel (for more informa-
tion, see Seb€ok et al., 2018, Methods).13
BOLD-cerebrovascular reactivity maps. The BOLD-CVR
calculations were done according to a previously
described analysis pipeline.12 The analysis included a
voxel-wise temporal shifting for optimal physiological
correlation of the BOLD signal and BOLD-CO2 time
series. BOLD-CVR, defined as the percentage BOLD
signal change/mmHg CO2, was then calculated from
the slope of a linear least square fit of the BOLD
signal time course to the CO2 time series over the
range of the first baseline of 100 seconds, the step por-
tion of the protocol (80 seconds) and the second base-
line of 100 seconds on a voxel-by-voxel basis. During
the baseline portions of the protocol, all subjects were
clamped on their resting CO2 baseline. The extra
BOLD fMRI volumes were acquired to allow for
potential temporal shift.17
Transcranial doppler ultrasound technique
TCD examinations including color coded intra- and
extracranial, transorbital and transforaminal sonogra-
phy were performed on an Accuson Siemens X2000
duplex scanner. The arterial segments were routinely
analyzed according to standardized methods as previ-
ously published.6 Grading of a stenosis of the contra-
lateral ICA was performed by duplex sonography
according to the NASCET criteria.18 Intracranial ste-
nosis was graded according to established and pub-
lished criteria.19
Assessment of MR angiographic circle of willis
anatomy and TCD derived collateral circulation
pathways
Two imaging techniques were used to assess the ana-
tomical and functional collateral status:
1. TOF-MRA to classify the anatomy of the Circle of
Willis and the number of available anatomical col-
laterals, and
2. TCD to identify presence of collateral activation of
primary and secondary collateral pathways.
Circle of willis in TOF-MRA. Time-of-Flight (TOF)-mag-
netic resonance angiography (MRA) of the first MRI
performed after hospital admission by diagnosis of uni-
lateral symptomatic ICA occlusion was used to classify
the anatomy of the Circle of Willis (CoW). The follow-
ing vessels were assessed as present or not present:
ACOM, A1-segments of anterior cerebral artery,
PCOM, P1-segment of posterior communicating
artery (PCA). Furthermore, the configuration of a
full (no PCA-P1-segment assessable) or partial
(PCOM larger in size than the PCA-P1-segment) fetal
posterior communicating artery was assessed. If TOF-
MRA was not fully conclusive, contrast enhanced
MRA (only if performed in the same MRI-
investigation) was used to determine CoW anatomy.
For determination of collateral status of the patient,
the ophthalmic artery was assessed for absence or pres-
ence of flow signal on TOF-MRA.
The CoW in TOF-MRA images were evaluated
independently by two neuroradiologists (S.Wi. with
10 years of experience and N.L. with two years of expe-
rience) blinded to the clinical data. Disagreements were
settled by consensus.
TCD examination of collateral pathways. All TCD measure-
ments were performed in clinical routine by an experi-
enced vascular neurologist or a resident neurologist in
the presence of an experienced vascular neurologist.
We collected the results through medical chart review
and evaluation of the saved ultrasound images from the
TCD investigation. The identification of the four main
collateral pathways that can be assessed with TCD, was
done as follows.6,20,21
1. ACOM: Reversed flow direction in the first (A1)
segment of the ACA ipsilateral to the occluded ICA
2. PCOM: cerebral blood flow increase of> 50% in the
ipsilateral first (P1) segment of the PCA compared
with the contralateral side
3. Ophthalmic artery (OA): reversed flow in the peri-
orbital arteries along with an internalized flow
profile
4. Leptomeningeal (LPM) collateral activation: flow
increase of> 30% in the ipsilateral second (P2) seg-
ment of the posterior cerebral artery (PCA) com-
pared with the contralateral P2 segment (Figure 2
(a) and (b)). Important to mention is that leptome-
ningeal collateral activation for TCD implies the
leptomeningeal collateral pathway supplied by the
posterior circulation.
Activated collateral pathways. Using the number of avail-
able anatomical collaterals and number of activated
collaterals as assessed by Doppler TCD investigation,
we demonstrate the percentage (%) of activated
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collaterals as the quotient between activated collaterals
in TCD and possible collaterals in anatomical images.
Here, for the number of possible collaterals we used the
data for ACOM and PCOM from TOF MRA images,
for ophthalmic artery the measured flow in Doppler
TCD verified for presence of possible collateral since
the ophthalmic artery identification in TOF MRA is
due to anatomical conditions limited.22 If no ophthal-
mic artery flow was measurable in TCD and no oph-
thalmic artery identifiable in TOF MRA, we counted
as no anatomical possibility for ophthalmic collateral.
Leptomeningeal collaterals were in all patients consid-
ered as anatomically possible.
Activation of maximal four collateral pathways
(ACOM, PCOM, ophthalmic and leptomeningeal col-
laterals) is possible. However, after anatomical correc-
tion there are also patients with only three or two
anatomically possible collaterals. Therefore, the quo-
tient between activated collaterals in TCD and possible
collaterals in anatomical images is always calculated
for the corrected number of anatomical collaterals.
For example: in patient with three possible collaterals
as seen in TOF MRA and activation of two of those
collaterals in TCD, the percentage of activated collat-
erals is calculated as: 2/3 * 100%¼ 67%.
DWI masking
Each infarct volume were manually outlined on diffu-
sion weighted imaging (DWI) with apparent diffusion
coefficient (ADC) sequences by a board certified neu-
roradiologist (S.Wi.) with 10 years of experience using
MRIcro software (version 1.4; Chris Rorden). The
acute phase sequences were used for infarct volume
analysis. When multiple ischemic infarct lesions were
present, the cumulative infarct volume would represent
the sum of all the lesions. Based on the T1-weighted
imaging properties, infarct volumes were binarized,
transformed into Montreal Neurological Institute
space using SPM, and calculated as the sum of the
number of voxels (in ml).
Statistical analysis
All statistical analyses were carried out using R (R
Core Team, 2020).23 All continuous variables are
reported as mean SD. Categorical ordinal variables
are presented as median (interquartile range (IQR)),
whereas dichotomous variables are shown as frequency
(%). Continuous variables were compared by an inde-
pendent Students 2-tailed t test, where p< 0.05 was
considered statistically significant. ANOVA was used
to calculate the between group differences. Prediction
analysis to evaluate the relationship between activated
collaterals and BOLD-CVR values of the ipsilateral
hemisphere were done using univariate and multivari-
ate analysis and evaluated using the R Squared (R2)
diagnostic. The predictive quality was assessed using
the Akaike Information Criterion (AIC). To avoid




During the study period, 85 patients with symptomatic
carotid artery occlusion, who presented at the Clinical
Neuroscience Center of University Hospital Zurich,
Switzerland were screened for participation in this
study. Of these, 68 patients were diagnosed with
untreated symptomatic unilateral ICA occlusion and
underwent BOLD-CVR investigation. Since in six
patients no TCD study was available, 62 participants
were considered for further analysis. A flow-chart illus-
trating patient screening and inclusion can be reviewed
in Figure 1.
Mean age of the included patients was 65.6
11.6 years, 14 (22.6%) were female. All patients pre-
sented with permanent or transient ischemic clinical
symptoms prior to imaging diagnosis of new ICA
occlusion. Forty-six patients presented with ischemic
stroke, 13 with TIA and 3 with TMB. The mean infarct
volume in patients presenting with ischemic stroke was
6.78 9.88ml. The median time between the neurolog-
ical symptoms (TIA, TMB or ischemic stroke) and
BOLD-CVR investigation was five days (interquartile:
17 days). The median time between the neurological
symptoms and TCD study was two days (interquartile:
five days). The patients had the following cerebrovas-
cular risk factors: 40 (64.5%) patients had hyperten-
sion, 12 (19.4%) had diabetes, 30 (48.4%)
hypercholesterolemia, four (6.5%) patients carried a
positive family history for cerebral ischemic events
and 13 (21.0%) had reported obesity. Thirty (48.4%)
patients were active or previous long-term smokers.
The baseline values of TCD assessment of flow
(peak systolic velocity and end diastolic velocity) for
relevant intracranial arteries measured ipsilateral and
contralateral to ICA occlusion can be reviewed in
Supplementary Table 1.
Cerebrovascular reserve capacity and collateral
circulation status in patients with symptomatic
carotid occlusion
Table 1 presents the baseline BOLD-CVR values and
TCD-derived collateral vessel status of 62 patients with
symptomatic unilateral carotid artery occlusion.
Exemplary BOLD-CVR images and TCD based
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collateral status evaluation of two patients with right
sided ICA occlusion can be reviewed in Figure 2.
Calculating the quotient between number of affected
collaterals in TCD and number of for activation pos-
sible collaterals (as seen in TOF MRA), six (9.7%) of
patients had 0% collateral activation as identified by
TCD examination according to the above-mentioned
criteria (see 2.4.2 Methods section).Twelve (19.4%)
patients had 25-33% activation, 24 (38.7%) patients
had 50-67% activation, 14 (22.6%) patients had 75%
activation and six (9.7%) patients had 100% activa-
tion. The relationship between % of collateral activa-
tion and mean BOLD-CVR values of ipsilateral
hemisphere is demonstrated in Figure 3.
Significantly lower mean BOLD-CVR value of the
ipsilateral hemisphere was found in patients with 75%
of available collaterals activated compared to those
with activated 25-33% of available collaterals (mean
BOLD-CVRSD: 75%: 0.05 0.07 vs. 25-33%:
0.12 0.05, p¼ 0.02). Even better pronounced is the
BOLD-CVR difference of ipsilateral hemisphere
between patients with activated 100% available
Table 1. BOLD-CVR values and collateral vessel status of





Hemodynamic BOLD-CVR data (meanSD)
Mean BOLD-CVR whole brain 0.11 0.07
Mean BOLD-CVR grey matter 0.13 0.08







TCD collateral vessel status data, n (%)
ACOM collateral 42 (67.7)
PCOM collateral 12 (19.4)
Ophthalmic collateral 36 (58.1)
Leptomeningeal collateral 27 (43.5)




aThe ipsilateral hemisphere is considered the hemisphere on the side of
the symptomatic ICA occlusion.
Figure 1. Study flow chart. From 150 patients with symptomatic carotid artery disease included in our prospective BOLD-CVR
database, 85 patients were diagnosed with symptomatic carotid artery occlusion. Out of them, 68 patients presented with untreated
symptomatic unilateral (maximal stenosis of 50% of the contralateral ICA) carotid artery occlusion and underwent a BOLD-CVR
study and were available for inclusion in this prospective cohort study. In six patients out of 68, no TCD study was available. In the final
analysis, 62 patients with untreated unilateral symptomatic ICA occlusion, who underwent both, BOLD-CVR and TCD investigation,
were included.
BOLD: blood oxygen-level dependent; CVR: cerebrovascular reactivity; ICA: internal carotid artery; TCD: transcranial Doppler.
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Figure 2. Schematic representation of collateral pathways and exemplary BOLD-CVR images of two patients with right ICA
occlusion. (a) The figure shows the available four collateral pathways (two primary collaterals and two secondary collaterals) in
patients with unilateral ICA occlusion. The two primary collaterals, which are part of the Circle of Willis, are ACOM and PCOM.
Activation of ACOM is detected as reversed flow direction in the first (A1) segment of the anterior cerebral artery ipsilateral to the
occluded ICA. Activation of PCOM is identified as cerebral blood flow increase of> 50% in the ipsilateral first (P1) segment of the
posterior cerebral artery compared with the contralateral side. The two TCD-derived secondary collaterals are ophthalmic and
leptomeningeal collaterals supplied by the posterior circulation. Activation of ophthalmic collaterals is detected as reversed flow in the
periorbital arteries and activation of leptomeningeal collaterals as flow increase of> 30% in the ipsilateral second (P2) segment of
posterior cerebral artery compared with the contralateral P2 segment. (B) The figure shows activation of leptomeningeal collaterals
on the surface of the ipsilateral (¼side of ICA occlusion) hemisphere with impaired (¼paradox) CVR in this hemisphere. (c) BOLD-
CVR image of a 48-years old patient with occlusion of right ICA showed preserved CVR in the territory of the occluded vessel. The
TCD examination showed only primary activation through ACOM with reversed flow direction in the right ACA-A1 segment. (d)
BOLD-CVR image of 85-years old patient with occlusion of right ICA showed impaired CVR in the territory of the occluded vessel.
The TCD examination showed: 1) right sided PCOM activation with 184% increase of SFV of the right PCA-P1 segment compared to
the contralateral PCA-P1, 2) reversed flow in the right ophthalmic artery indicating right sided ophthalmic activation, and 3) activation
of leptomeningeal collateral pathways supplied by the posterior circulation on the ride side with 130% increase of SFV of the right
PCA-P2 segment compared to the contralateral PCA-P2.
ACA-A1: first segment of anterior cerebral artery; ACOM: anterior communicating artery; BOLD: blood oxygenation-level dependent;
CVR: cerebrovascular reactivity; ICA: internal carotid artery; PCA-P1: first segment of posterior cerebral artery; PCA-P2: second
segment of posterior cerebral artery; PCOM: posterior communicating artery; SFV: systolic flow velocity; TCD: transcranial Doppler.
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collaterals and 25-33% available collaterals (mean
BOLD-CVRSD: 0.02 0.06 vs. 0.12 0.05,
p¼ 0.006). Markedly impaired BOLD-CVR of ipsilat-
eral hemisphere was seen also in patients with 100%
collateral activation compared to patients with 50-67%
collateral activation (mean BOLD-CVRSD: 0.02
0.06 vs. 0.10 0.09, p¼ 0.05) (Figure 3). The between
groups difference in ipsilateral BOLD-CVR values by
one-way ANOVA is p¼ 0.03.
Impact of activation of primary collaterals on
patientshemodynamic status
Patients with ACOM activation (42 patients) showed
higher BOLD-CVR values in the ipsilateral hemisphere
as compared to patients without ACOM activation
(mean BOLD-CVR SD: 0.10 0.08 vs. 0.06 0.08,
p¼ 0.07). Interestingly, patients with PCOM activation
(14 patients) showed a clear significant BOLD-CVR
decrease in the ipsilateral hemisphere as opposed to
patients without PCOM activation (mean BOLD-
CVR SD: 0.04 0.08 vs. 0.10 0.07, p¼ 0.006).
Impact of activation of secondary collaterals on
patientshemodynamic status
Patients with activated secondary collaterals (with or
without primary collaterals) exhibited significantly
lower BOLD-CVR values of ipsilateral hemisphere as
compared to patients with only primary collaterals
activation (mean BOLD-CVR SD: 0.07 0.08 vs.
0.13 0.05, p¼ 0.02).
Patients with activation of ophthalmic collaterals
(36 patients) showed significantly lower BOLD-CVR
values in the ipsilateral hemisphere as compared to
patients without ophthalmic activation (mean BOLD-
CVR SD: 0.07 0.07 vs. 0.11 0.08, p¼ 0.05).
Activation of leptomeningeal collaterals is associated
with even lower BOLD-CVR values – mean BOLD-
CVR of ipsilateral hemisphere of patients without
Figure 3. Correlation between percentage of activated available collaterals and mean ipsilateral hemisphere BOLD-CVR values. Box-
whisker plots show the correlation between the percentages of activated available collaterals and mean BOLD-CVR values of the
ipsilateral hemisphere. Patients with more activated collaterals exhibit significantly lower CVR values: patients with 75% and 100% of
activated available collaterals have significantly lower mean BOLD-CVR of ipsilateral hemisphere as compared to patients with
activated 25-33% of available collaterals; patients with 100% collateral activation exhibit significantly lower CVR values compared to
patients with 50-67% collateral activation. Activation of maximal four collateral pathways (ACOM, PCOM, ophthalmic artery, and
leptomeningeal collateral pathways supplied by the posterior circulation) is possible. However, after anatomical correction there are
also patients with only three or two anatomically possible collaterals. Therefore, the quotient between activated collaterals in TCD
and possible collaterals in anatomical images is always calculated for the corrected number of anatomical collaterals. For example: in
patient with three possible collaterals as seen in TOF MRA and activation of two of those collaterals in TCD, the percentage of
activated collaterals is calculated as: 2/3 * 100%¼ 67%. Patients with activation of 1/4 and 1/3 of anatomically available collaterals form
the 25-33% group and patients with activation of 1/2 and 2/3 of anatomically available the 50-67% group.
Note: The box of box-whisker plots represents the median value with interquartile range (25th to the 75th percentile). The upper and
lower whiskers represent values outside the middle 50% (i.e., the values below 25th and above 75th percentile).
BOLD: blood oxygen-level dependent; CVR: cerebrovascular reactivity.
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leptomeningeal collaterals vs. patients with leptome-
ningeal collaterals: 0.04 0.09 vs. 0.12 0.04,
p< 0.001.
By studying the impact of secondary collaterals acti-
vation, patients were divided into three groups: group 1
without activation of ophthalmic and leptomeningeal
collaterals, group 2 with activation of ophthalmic and
without activation of leptomeningeal collaterals and
group 3 with activation of leptomeningeal collaterals
and with/without activation of ophthalmic collaterals.
A significant lower mean BOLD-CVR value of
ipsilateral hemispheres is seen in patients with activated
leptomeningeal collaterals (group 3) compared to
those without any secondary collaterals (group 1)
(mean BOLD-CVR SD: 0.05 0.09 vs. 0.13 0.05,
p¼ 0.003) as well as between group 2 (activation of
ophthalmic collaterals without leptomeningeal
activation) and group 3 (activation of leptomeningeal
collaterals with/without ophthalmic collaterals):
mean BOLD-CVRSD: 0.05 0.09 vs. 0.12 0.04,
p¼ 0.005 (Figure 4). The between groups difference
for ipsilateral BOLD-CVR values by one-way
ANOVA is p¼ 0.001.
Effect of PCOM and leptomeningeal collateral
activation on CVR
Since patients with PCOM activation (independent
of activation status of other possible collaterals)
exhibit a mean ipsilateral hemisphere BOLD-CVR
value of 0.04 0.08 and patients with activation of lep-
tomeningeal collaterals (independent of activation
status of other possible collaterals) a mean ipsilateral
hemisphere BOLD-CVR value of 0.04 0.09, to dem-
onstrate the true impact of PCOM and LPM collater-
als, the patients were divided into four groups: group 1
without activation of PCOM and leptomeningeal col-
laterals, group 2 with activation of only PCOM collat-
erals, group 3 with activation of only leptomeningeal
collaterals and group 4 with activation of both, PCOM
and LPM collaterals. No BOLD-CVR difference is
seen between group 2 and 3, but a significantly lower
Figure 4. Correlation between different stages of secondary collaterals activation and mean ipsilateral hemisphere BOLD-CVR
values. Box-whisker plots show the correlation between the three groups of patients with different secondary collaterals activation
status and BOLD-CVR values of ipsilateral hemisphere. Patients with activated leptomeningeal collateral pathways supplied by the
posterior circulation with/without activation of ophthalmic collaterals (group 3) exhibit significantly lower mean BOLD-CVR values of
ipsilateral hemisphere compared to patients without any secondary collaterals (group 1) (mean BOLD-CVR SD: 0.050.09 vs.
0.130.05, p¼0.003) as well as compared to patients with activation of only ophthalmic collaterals (group 2) (mean BOLD-CVR SD:
0.050.09 vs. 0.120.04, p¼0.005). No difference is BOLD-CVR values is discernible between patients without any activated
secondary collaterals and between patients with only ophthalmic activation. The between groups difference for ipsilateral BOLD-CVR
values by one-way ANOVA is p¼0.001.
Note: The box of box-whisker plots represents the median value with interquartile range (25th to the 75th percentile). The upper and
lower whiskers represent values outside the middle 50% (i.e., the values below 25th and above 75th percentile).
ANOVA: analysis of variance; BOLD: blood oxygen-level dependent; CVR: cerebrovascular reactivity; SD: standard deviation.
8 Journal of Cerebral Blood Flow & Metabolism 0(0)
BOLD-CVR in group 4 (activated both, PCOM and
LPM collaterals) as compared to group 2 (mean
BOLD-CVRSD: 0.01 0.06 vs. 0.12 0.06, p¼
0.003) as well as compared to group 3 (mean BOLD-
CVR SD: 0.01 0.06 vs. 0.07 0.09, p¼ 0.03). The
between groups difference for ipsilateral BOLD-CVR
values by one-way ANOVA is p< 0.001. (Figure 5).
Investigation of quantitative flow velocity values
showed interesting results: the mean quantitative sys-
tolic PCA-P1 flow velocity did not differ between
patients in group 2 and 4 (116 80cm/s vs. 120 44,
p¼ 0.91). This indicates that the lower BOLD-CVR of
ipsilateral hemisphere found in patients with PCOM
activation is primarily driven by leptomeningeal
activation.
Using prediction analysis to determine the indepen-
dent effect of each collateral pathway on BOLD-CVR of
the ipsilateral hemisphere, in the univariate analysis
PCOM collaterals (R2¼ 0.11, p¼ 0.005) and leptome-
ningeal collaterals (R2¼ 0.21, p< 0.001) showed a sig-
nificant association with BOLD-CVR, while ophthalmic
and ACOM activation did not. In the multivariate anal-
ysis (R2¼ 0.30), leptomeningeal activation (p¼ 0.003)
remained the sole collateral pathway independently pre-
dict the BOLD-CVR of the ipsilateral hemisphere
(PCOM activation: p¼ 0.06, ophthalmic activation:
p¼ 0.09).
Discussion
In this study, we examined symptomatic unilateral ICA
occlusion patients with BOLD-CVR and TCD to
determine which collateral pathway activation have
influence on BOLD-CVR by evaluating primary collat-
eral activation (ACOM and PCOM activation) and
secondary collateral activation (ophthalmic artery and
leptomeningeal artery activation). Our data demon-
strate that only activation of leptomeningeal collateral
pathways as measured by the difference of >30%
between the ipsilateral and contralateral PCA-P2 flow
velocity was associated with impaired BOLD-CVR in
the ipsilateral hemisphere in patients with symptomatic
Figure 5. Correlation between different stages of PCOM and leptomeningeal collaterals activation and mean ipsilateral hemisphere
BOLD-CVR values. Box-whisker plots show the correlation between the groups of patients with different activation status of PCOM
and leptomeningeal collateral pathways supplied by the posterior circulation and BOLD-CVR values of ipsilateral hemisphere. Patients
with activated both, PCOM and leptomeningeal collaterals (group 4) exhibit significantly lower mean BOLD-CVR values of ipsilateral
hemisphere compared to patients with only PCOM activation (group 2) (mean BOLD-CVR SD: -0.010.06 vs. 0.120.06, p¼0.003)
and patients with only leptomeningeal activation (group 3) (mean BOLD-CVR SD: mean BOLD-CVR SD: -0.010.06 vs. 0.07
0.09, p¼0.03). The between groups difference for ipsilateral BOLD-CVR values by one-way ANOVA is p<0.001.
Note: The box of box-whisker plots represents the median value with interquartile range (25th to the 75th percentile). The upper and
lower whiskers represent values outside the middle 50% (i.e., the values below 25th and above 75th percentile).
ANOVA: analysis of variance; BOLD: blood oxygen-level dependent; CVR: cerebrovascular reactivity; PCOM: posterior communi-
cating artery; SD: standard deviation.
Seb€ok et al. 9
unilateral ICA occlusion. Although the activation of
the ophthalmic artery and PCOM activation were asso-
ciated with a more impaired BOLD-CVR, this associ-
ation was confounded by underlying leptomeningeal
collateral activation. Using a prediction analysis to
determine the independent effect of each collateral
pathway on BOLD-CVR of the ipsilateral hemisphere,
leptomeningeal collateral activation supplied by the
posterior circulation were shown to be independent
predictor of ipsilateral hemisphere BOLD-CVR.
Collateral status of patients with carotid occlusion
Patients with ICA occlusion and an impaired cerebro-
vascular reactivity are thought to have an increased
stroke risk.1–3 The rate of subsequent recurrent stroke
in patients with ICA occlusion has been estimated 2.4-
7% per year,25,26 but is significantly higher in patients
with impaired reactivity.27,28 Therefore, an identifica-
tion of patients with symptomatic ICA occlusion,
exhausted hemodynamic status and insufficient collat-
eral status plays a key role in treatment of those
patients. Moreover, a recent study also found that pres-
ence of hemodynamic impairment significantly short-
ened event-free survival during the follow-up in
patients with symptomatic carotid artery occlusion.29
Several previous studies linked the carotid occlusion in
patients with symptomatic cerebral ischemia with
hypoperfusion and in addition, exhaustion of compen-
satory reserve of the cerebral circulation.30–32 Severe
hemodynamic failure has been linked with recruitment
of collateral pathways, especially with leptomeningeal
collaterals.14,33,34 Many noninvasive imaging techniques
are standardly used to evaluate primary and secondary
collateral circulation.35,36 However, digital subtraction
angiography (DSA) remains the gold standard for struc-
tural and functional evaluation of collaterals,25,37 in
everyday clinical practice TCD is often used as
method of choice to assess collateral sufficiency.
Our results show an interesting pattern of collateral
activation: patients with ICA occlusion and activation
of only primary collateral pathways present with pre-
served BOLD-CVR, which is congruent with the earlier
findings in the literature.38,39 Activation of secondary
collaterals resulted in a decrease in BOLD-CVR, how-
ever this was only the case if leptomeningeal activation
was present. Retrograde flow in the ophthalmic artery
alone did not result in impaired BOLD-CVR. Previous
studies showed conflicting results regarding impact of
secondary collaterals: while some studies linked the
activation of secondary collaterals to impaired cerebral
vasoreactivity,11,21 others suggested that not the type
but the number of activated collateral pathways indi-
cates a higher risk of stroke recurrence in patients with
carotid artery occlusion.6,38,40
Connolly et al.41 assessed the activation of primary
and secondary collaterals in patients with symptomatic
ICA occlusion using TCD, and showed that ACOM
collateral was most frequently activated, followed by
ophthalmic, the PCOM and the leptomeningeal collat-
erals. In our cohort, likewise, ACOM collateral was
most frequently activated followed by ophthalmic.
Contrary, PCOM in our cohort was activated only in
20%, clearly less than leptomeningeal collaterals. This
could be due to the larger cerebral blood flow differ-
ence necessary to be present for PCOM activation
(>50%) as compared to leptomeningeal activation
(>30%) – see also Methods section. However, these
cut-offs are accepted as clinical standards. Secondly,
the TCD examination, which is operator dependent,
has to be considered.
Pathways of secondary collateral activation
The activation of secondary collaterals in addition to
primary collaterals was already in previous studies
related to compromised – exhausted – hemodynamic
status.6,11,14 A negative flow reactivity is significantly
associated with a dependence on leptomeningeal collat-
erals and implies a state of maximal hemodynamic
compromise. In 1994, Smith et al.42 in patients with
symptomatic cerebrovascular disease who underwent
angiography and xenon-enhanced computed tomo-
graphic cerebral blood flow studies before and after
acetazolamide found a significant association between
negative flow reactivity and a dependence on leptome-
ningeal collaterals indicating a state of maximal hemo-
dynamic compromise.
A recent study by Hartkamp et al.33 supports our
findings too, as the recruitment of secondary collaterals
was associated with severe hemodynamic impairment.
In their cohort, secondary collateral flow occurred only
in patients with symptomatic ICA occlusion, who also
had severe hemodynamic impairment of the affected
hemisphere. Based on these findings they hypothesized
that the occurrence of secondary collaterals is due to
critically insufficient primary collateral redistribution
via the Circle of Willis. Comparably, a recent study
using perfusion weighted imaging and quantitative
T2* mapping based assessment of leptomeningeal col-
laterals concluded that increased leptomeningeal collat-
eral supply cannot necessarily be regarded as a sign of
effective compensation in patients with high-grade
steno-occlusive vasculopathy.43 Our results confirm
this hypothesis. Moreover, with significantly lower
BOLD-CVR values in patients with activated leptome-
ningeal collaterals (independent of ophthalmic activa-
tion) as compared to patients with activated
ophthalmic collaterals without leptomeningeal collater-
als, a clear priority in activation of secondary
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collaterals is detectable. Namely, ophthalmic collater-
als activate first after the collateral flow through Circle
of Willis is not sufficient, and leptomeningeal as the last
one in the case of exhausted hemodynamic as a sort of
tertiary collateral pathway.
Impaired CVR and leptomeningeal activation as
indicators of exhausted cerebral hemodynamic
status in symptomatic carotid artery occlusion
Our results confirm the previously reported finding
that activation of leptomeningeal collaterals33,43 sug-
gests a compromised hemodynamic status. A similar
finding was reported by Strother et al.44 in patients
with Moyamoya disease, who find that the degree of
leptomeningeal collateral supply reflects the disease
severity. A significant association between activation
of leptomeningeal collaterals with/without PCOM as
well as between LPM with/without ophthalmic collat-
erals and impaired (even negative) BOLD-CVR of ipsi-
lateral hemisphere in our cohort, confirms the link
between activation of leptomeningeal collaterals and
exhausted BOLD-CVR. Moreover, we have shown
that the mean quantitative systolic PCA-P1 flow veloc-
ity did not differ between patients with only PCOM
activation and patients with both, PCOM and leptome-
ningeal collateral activation, indicating that the lower
BOLD-CVR of ipsilateral hemisphere found in patients
with PCOM activation is primarily driven by leptome-
ningeal activation.
Our prediction model showed that leptomeningeal
collateral activation supplied by the posterior circula-
tion is sole independently predictive of BOLD-CVR of
the ipsilateral hemisphere. As flow velocity measured
from TCD represents a combination of cerebral blood
flow and vessel radius, the higher PCA-P2 flow velocity
values may represent a functional stenosis rather than
just an increased cerebral blood flow due to increased
compensatory efforts for the need of the vascular bed.6
Both TCD defined activation of PCOM collaterals and
leptomeningeal collaterals are based on a difference
analysis between ipsilateral and contralateral PCA-P1
and PCA-P2 segment, respectively. The first risk of
such a difference analysis is false positive, especially
in patients with low contralateral flow velocity values.
However, it is also known that unilateral vasculopathy
can affect both hemispheres and in that case this dif-
ference analysis could result in false negative.12,45
Schneider et al.6 also found a bilateral increase in
PCA-P2 flow in patient with recurrent stroke. It is
expected, therefore, that more patients do have a func-
tional PCA-P1 and PCA-P2 stenosis and to have a
quantitative cut-off point would be more optimal to
define PCOM and leptomeningeal activation as the dif-
ference analysis. However, the clear difference between
patients with and without functional stenosis of the
PCA-P2 does show its clinical value as an easy param-
eter to evaluate.
Future considerations & clinical implications
To have a specific TCD parameter available, i.e. lep-
tomeningeal collateral activation, may further support
clinicians in screening a wide population of patients
with carotid artery occlusion and identify those,
whom may need a further cerebral hemodynamic
workup, for instance with BOLD-CVR. Specifically,
patients with ICA occlusion and TCD identified lepto-
meningeal activation may be those who need further
hemodynamic work-up with BOLD-CVR (or any
other imaging modality that can assess cerebral hemo-
dynamics) to detect those suffering from hemodynamic
failure. Secondly, this may also improve patient selec-
tion for revascularization strategies. This is important
not only to prevent recurrent ischemic strokes but also
to avoid a cognitive deterioration in the presence of
carotid occlusion, especially when associated to
impaired CVR.46,47 For future studies, however, it is
important to mention that a validation of the present
findings using a sensitivity and specificity analysis
would be of utmost clinical importance.
Limitations
The study represents single center-based findings in a
cohort of patients with symptomatic unilateral ICA
occlusion. A selection bias was introduced to the study
since especially patients with internal carotid occlusion,
who were suspected of having hemodynamic impair-
ment underwent a BOLD-CVR examination.
Similarly, neurologically more affected patients, restless
or anxious patients were rather not invited for BOLD
fMRI study, which means the sample is probably differ-
ent from the population with respect to its demographics
and health outcomes. With BOLD-CVR examination a
volunteer bias was introduced too, since patients had to
agree with study participation and sign an informed con-
sent. Contrary, examination of collateral status with
TCD was performed in clinical setting and therefore
done by several board-certified stroke neurologists,
introducing additional subjectivity to already operator-
dependent examination. Moreover, no re-TCDs were
performed to control the findings. TCD has methodo-
logical limitations to account for leptomeningeal collat-
eral flow – notably TCD cannot assess ACA to MCA as
major contributories for total leptomeningeal collateral
flow. The aim, however, was to assess TCD-derived lep-
tomeningeal collateral activation which can be assessed
from the posterior circulation.4,6,9,21 Moreover, using
TCD we cannot assess all external to internal carotid
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artery connections through facial, maxillary, middle
meningeal, and occipital arteries. Nonetheless from a
clinical point of view, TCD is considered a useful tool
to screen for collateral activation, based on four main
collateral pathways (2 primary, and 2 secondary) that
can be reliably assessed with TCD.4,6,9,21
Conclusions
In our study, TCD-derived ipsilateral leptomeningeal
collateral activation is the sole collateral pathway asso-
ciated with impaired BOLD-CVR in patients with
symptomatic unilateral ICA occlusion.
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